Task: Answer the multiple-choice question.
Question: Which drug exhibits a 11.236\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCCNC(=O)CSc1nc2ccc(OCC)cc2s1
b. COc1ccc(C(CNC(=O)COc2ccccc2OC)N2CCCCC2)cc1
c. CCOC(=O)c1c(C)[nH]c(C)c1C(=O)C(Cc1ccccc1)N(C)C.Cl
Answer: a. CCCNC(=O)CSc1nc2ccc(OCC)cc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)CSc1nc2ccc(OCC)cc2s1
CCCNC(=O)CSc1nc2ccc(OCC)cc2s1
2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-N-propylacetamide